Literature DB >> 1740502

Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.

J N Clore1, E P Post, D J Bailey, J E Nestler, W G Blackard.   

Abstract

In order to assess hepatic glycogen stores in patients with noninsulin dependent diabetes mellitus (NIDDM) after a 3-day fast, the incremental glucose response to 1.0 mg iv glucagon (glucose area under the curve, glucoseAUC) was assessed in 19 obese diabetic subjects after an overnight (14 h) fast and again after a 3-day (64 h) fast. Results were compared to those of lean (n = 6) and obese (n = 15) nondiabetic subjects. During the fast, plasma glucose fell significantly in the lean (4.9 +/- 0.2 to 3.9 +/- 0.2 mmol/L), obese (5.1 +/- 0.1 to 4.2 +/- 0.2 mmol/L), and diabetic (14.7 +/- 0.7 to 10.3 +/- 1.0 mmol/L) subjects. However, in contrast to the fall in glucoseAUC observed in the lean (92.4 +/- 15.4 to 39.9 +/- 8.1 mmol min-1 L-1, P less than 0.02) and obese (64.4 +/- 11.1 to 48.4 +/- 9.4 mmol min-1 L-1) subjects, the glucoseAUC increased in diabetic subjects from 81.6 +/- 8.6 to 103.9 +/- 8.8 mmol min-1 L-1 during the fast, and was significantly greater than that of either the lean (P less than 0.001) or obese (P less than 0.001) nondiabetic subjects after the 64-h fast. Evidence that the glucose response to glucagon after a 64-h fast represents glycogenolysis and not gluconeogenesis was provided by studies in 10 additional subjects (5 obese nondiabetic subjects and 5 patients with NIDDM). Overall hepatic glucose output calculated from glucose kinetic data [( 3-3H]glucose) increased in diabetic and nondiabetic subjects during the first 30 min after glucagon administration and fell progressively thereafter. However, no increase in alanine gluconeogenesis (14C-alanine incorporation into glucose) was observed after glucagon administration in either subject group. The paradoxical accumulation of glycogen in the patients with NIDDM during the fast occurred despite basal rates of hepatic glucose output on the third day of the fast which were greater than those of obese nondiabetic subjects (9.0 +/- 1.2 vs. 5.6 +/- 0.5 mumol kg-1 min-1, P less than 0.05). A glycogen sparing action of increased gluconeogenesis is proposed as the explanation for the preservation of liver glycogen in patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740502     DOI: 10.1210/jcem.74.3.1740502

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Hepatic glucose production pathways after three days of a high-fat diet.

Authors:  Eunsook S Jin; Sara A Beddow; Craig R Malloy; Varman T Samuel
Journal:  Metabolism       Date:  2012-09-12       Impact factor: 8.694

2.  MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST).

Authors:  Peter C M van Zijl; Craig K Jones; Jimin Ren; Craig R Malloy; A Dean Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

3.  Loss of hepatic autoregulation after carbohydrate overfeeding in normal man.

Authors:  J N Clore; S T Helm; W G Blackard
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

4.  The action of aminoguanidine on the liver of trained diabetic rats.

Authors:  Edmara Tereza Meira E Nico; Patrícia Rosa de Oliveira; Leonardo Peres de Souza; Franco Dani Campos Pereira; Maria Andréia Delbin; Angelina Zanesco; Maria Izabel Camargo-Mathias
Journal:  J Diabetes Metab Disord       Date:  2013-07-09

5.  Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus.

Authors:  Julia Marchal; Stéphane Blanc; Jacques Epelbaum; Fabienne Aujard; Fabien Pifferi
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

6.  Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.

Authors:  Manoj Amrutkar; Emmelie Cansby; Urszula Chursa; Esther Nuñez-Durán; Belén Chanclón; Marcus Ståhlman; Vincent Fridén; Louise Mannerås-Holm; Anna Wickman; Ulf Smith; Fredrik Bäckhed; Jan Borén; Brian W Howell; Margit Mahlapuu
Journal:  Diabetes       Date:  2015-04-06       Impact factor: 9.461

7.  AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.

Authors:  Nikolaos Nikolaou; Laura L Gathercole; Lea Marchand; Sara Althari; Niall J Dempster; Charlotte J Green; Martijn van de Bunt; Catriona McNeil; Anastasia Arvaniti; Beverly A Hughes; Bruno Sgromo; Richard S Gillies; Hanns-Ulrich Marschall; Trevor M Penning; John Ryan; Wiebke Arlt; Leanne Hodson; Jeremy W Tomlinson
Journal:  Metabolism       Date:  2019-07-19       Impact factor: 8.694

8.  Assessment of Rapid Hepatic Glycogen Synthesis in Humans Using Dynamic 13C Magnetic Resonance Spectroscopy.

Authors:  Stefan Stender; Vlad G Zaha; Craig R Malloy; Jessica Sudderth; Ralph J DeBerardinis; Jae Mo Park
Journal:  Hepatol Commun       Date:  2020-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.